Spectral Medical Inc. EDT.TO
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.60% | 27.33% | 4.90% | 31.23% | 29.28% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.60% | 27.33% | 4.90% | 31.23% | 29.28% |
| Cost of Revenue | -6.30% | -22.93% | -31.69% | -15.34% | -8.85% |
| Gross Profit | 12.00% | 137.77% | 90.92% | 155.11% | 130.80% |
| SG&A Expenses | -6.14% | -9.48% | -0.39% | -0.72% | -0.84% |
| Depreciation & Amortization | 23.72% | -72.92% | -76.03% | -78.33% | -78.74% |
| Other Operating Expenses | -13.76% | 0.05% | 38.79% | 11.26% | -7.40% |
| Total Operating Expenses | -5.99% | -13.28% | -7.19% | -5.90% | -5.66% |
| Operating Income | 7.89% | 19.83% | 9.48% | 11.88% | 10.96% |
| Income Before Tax | -70.14% | -61.58% | -200.93% | -62.96% | -10.67% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -70.14% | -61.58% | -200.93% | -62.96% | -10.67% |
| Earnings from Discontinued Operations | 56.00% | 56.00% | 58.82% | 79.42% | 95.87% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -70.10% | -61.55% | -200.81% | -62.77% | -9.74% |
| EBIT | 7.89% | 19.83% | 9.48% | 11.88% | 10.96% |
| EBITDA | 8.13% | 20.05% | 9.55% | 12.10% | 11.09% |
| EPS Basic | -67.66% | -58.77% | -194.09% | -59.30% | -8.03% |
| Normalized Basic EPS | -67.36% | -58.73% | -194.09% | -63.25% | -13.09% |
| EPS Diluted | -67.66% | -58.77% | -194.09% | -59.30% | -8.03% |
| Normalized Diluted EPS | -67.36% | -58.73% | -194.09% | -63.25% | -13.09% |
| Average Basic Shares Outstanding | 2.69% | 2.37% | 2.10% | 1.82% | 1.63% |
| Average Diluted Shares Outstanding | 2.69% | 2.37% | 2.10% | 1.82% | 1.63% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |